TrialClinical pharmacology in drug development2025
Combined Immediate-Release and Extended-Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation.
Nikhil Ahuja et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.